The first batch of Russian vaccine — Sputnik V — is likely to reach Ganesh Shankar Vidyarthi Medical College in Kanpur by next week wherein the Phase 2 and Phase 3 human clinical trials for coronavirus vaccine will be conducted.
The decision to conduct the human clinical trials of the coronavirus vaccine comes after Dr Reddy’s Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard.
Also Read | Third COVID-19 vaccine is ‘almost ready’: Russia
The college principal RB Kamal said that the human clinical trials of the Sputnik V vaccine will start from the next week.
Kamal said that the vitals and condition of volunteers’ will be checked periodically while the data will be analysed to find out whether the vaccine was a success or not.
The effect of the Russian vaccine Sputnik V on volunteers will be studied for 7 months after the same would be administered once, twice, or thrice within an interval of 21 days, he added.
After observing the effects of the vaccine, the authorities will be apprised of the trials’ results. The authorities will then make a decision, accordingly.
On August 11, the Ministry of Health of Russia registered the Sputnik V vaccine and became the world’s first registered vaccine against COVID-19.